Nevertheless, GSK3β has been long known to be up-regulated in the brain and spinal cord of ALS patients [31,32] and contribute to pathogenesis, specifically by affecting neuronal metabolic integrity [33]. Here, GSK3B is linked to amyotrophic lateral sclerosis.